Severe Sepsis Completed Phase 3 Trials for Clarithromycin (DB01211)

Also known as: Sepsis, Severe

IndicationStatusPhase
DBCOND0031268 (Severe Sepsis)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01223690Clarithromycin as Immunomodulator for the Management of SepsisTreatment